Arthroscopic surgery for degenerative knee arthritis and meniscal tears: a clinical practice guideline
======================================================================================================

* Reed A C Siemieniuk
* Ian A Harris
* Thomas Agoritsas
* Rudolf W Poolman
* Romina Brignardello-Petersen
* Stijn Van de Velde
* Rachelle Buchbinder
* Martin Englund
* Lyubov Lytvyn
* Casey Quinlan
* Lise Helsingen
* Gunnar Knutsen
* Nina Rydland Olsen
* Helen Macdonald
* Louise Hailey
* Hazel M Wilson
* Anne Lydiatt
* Annette Kristiansen

#### What you need to know

*   We make a strong recommendation against the use of arthroscopy in nearly all patients with degenerative knee disease, based on linked systematic reviews; further research is unlikely to alter this recommendation

*   This recommendation applies to patients with or without imaging evidence of osteoarthritis, mechanical symptoms, or sudden symptom onset

*   Healthcare administrators and funders may use the number of arthroscopies performed in patients with degenerative knee disease as an indicator of quality care.

*   Knee arthroscopy is the most common orthopaedic procedure in countries with available data

*   This Rapid Recommendation package was triggered by a randomised controlled trial published in *The BMJ* in June 2016 which found that, among patients with a degenerative medial meniscus tear, knee arthroscopy was no better than exercise therapy 

What is the role of arthroscopic surgery in degenerative knee disease? An expert panel produced these recommendations based on a linked systematic review triggered by a randomised trial published in *The BMJ* in June 2016, which found that, among patients with a degenerative medial meniscus tear, knee arthroscopy was no better than exercise therapy. The panel make a strong recommendation against arthroscopy for degenerative knee disease. Box 1 shows all of the articles and evidence linked in this Rapid Recommendation package. The infographic provides an overview of the absolute benefits and harms of arthroscopy in standard GRADE format. Table 2 below shows any evidence that has emerged since the publication of this article.

#### Box 1: Linked articles in this *BMJ* Rapid Recommendations cluster

*   Siemieniuk RAC, Harris IA, Agoritsas T, et al. Arthroscopic surgery for degenerative knee arthritis and meniscal tears: a clinical practice guideline. *BMJ* 2017;257:j1982. doi:[10.1136/bmj.j1982](https://www.bmj.com/lookup/doi/10.1136/bmj.j1982)
    
    *   Summary of the results from the Rapid Recommendation process

*   Brignardello-Peterson R, Guyatt GH, Schandelmaier S, et al. Knee arthroscopy versus conservative management in patients with degenerative knee disease: a systematic review. *BMJ Open* 2017;7:e016114. doi:[doi:10.1136/bmjopen-2017-161114](http://bmjopen.bmj.com/content/7/5/e016114)
    
    *   Review of all available randomised trials that assessed the benefits of knee arthroscopy compared with non-operative care and observational studies that assessed risks 

*   Devji T, Guyatt GH, Lytvyn L, et al. Application of minimal important differences in degenerative knee disease outcomes: a systematic review and case study to inform BMJ Rapid Recommendations. *BMJ Open* 2017;7:e015587. doi:[doi:10.1136/bmjopen-2016-015587](http://bmjopen.bmj.com/content/7/5/e015587)
    
    *   Review addressing what level of individual change on a given scale is important to patients (minimally important difference). The study informed sensitivity analyses for the review on net benefit, informed discussions on patient values and preferences, and was key to interpreting the magnitude of effect sizes and the strength of the recommendation

*   MAGICapp ([www.magicapp.org](http://www.magicapp.org))
    
    *   Expanded version of the results with multilayered recommendations, evidence summaries, and decision aids for use on all devices

## Current practice

Approximately 25% of people older than 50 years experience knee pain from degenerative knee disease (box 2).2 3 Management options include watchful waiting, weight loss if overweight, a variety of interventions led by physical therapists, exercise, oral or topical pain medications such as non-steroidal anti-inflammatory drugs, intra-articular corticosteroid and other injections, arthroscopic knee surgery, and knee replacement or osteotomy. The preferred combination or sequence of these options is not clear and probably varies between patients.

#### Box 2: What is degenerative knee disease?

*   Degenerative knee disease is an inclusive term, which many consider synonymous with osteoarthritis. We use the term degenerative knee disease to explicitly include patients with knee pain, particularly if they are >35 years old, with or without:
    
    *   Imaging evidence of osteoarthritis
    
    *   Meniscus tears
    
    *   Locking, clicking, or other mechanical symptoms except persistent objective locked knee
    
    *   Acute or subacute onset of symptoms

*   Most people with degenerative arthritis have at least one of these characteristics.1 The term degenerative knee disease does not include patients having recent debut of their symptoms after a major knee trauma with acute onset of joint swelling (such as haemarthrosis)

Knee replacement is the only definitive therapy, but it is reserved for patients with severe disease after non-operative management has been unsuccessful.4 5 Some believe that arthroscopic debridement, including washout of intra-articular debris, with or without arthroscopic partial meniscectomy to remove damaged meniscus, may improve pain and function.

Current guidelines generally discourage arthroscopy for patients with clear radiographic evidence of osteoarthritis alone, but several support or do not make clear statements regarding arthroscopic surgery in other common groups of patients (table 1⇓).

View this table:
[Table 1](https://www.bmj.com/content/357/bmj.j1982/T1)

Table 1 
Support from current guidance for arthroscopic surgery in patients with subgroups of degenerative knee disease

Arthroscopic knee surgery for degenerative knee disease is the most common orthopaedic procedure in countries with available data14 and on a global scale is performed more than two million times each year (fig 1⇓).15 16 17 18 Arthroscopic procedures for degenerative knee disease cost more than $3bn per year in the US alone.19 A high prevalence of features advocated to respond positively to arthroscopic surgery (such as meniscal tears, mechanical symptoms, and sudden symptom onset) as well as financial incentives may explain why arthroscopic knee surgery continues to be so common despite recommendations against its use for osteoarthritis. Further, patients may be frustrated with their symptoms, having tried several less invasive management strategies by the time that they see the surgeon, and in many cases this may come with an expectation for surgical management. Moreover, many patients experience important and marked improvements after arthroscopy, which may be erroneously attributed to the effects of the procedure itself instead of the natural course of the disease, co-interventions, or placebo effects.

![Figure1](https://www.bmj.com/https://www.bmj.com/content/bmj/357/bmj.j1982/F1.medium.gif)

[Figure1](https://www.bmj.com/content/357/bmj.j1982/F1)

**Fig 1** Population adjusted trends in frequency of knee arthroscopy; percent. Arthroscopic knee surgery remains common despite accumulating evidence suggesting little benefit

#### How the recommendation was created

A randomised controlled trial published in *The BMJ* in June 2016 found that, among patients with a degenerative medial meniscus tear, knee arthroscopy was no better than exercise therapy.32 This study adds to the body of evidence suggesting that the benefits of arthroscopy may not outweigh the burden and risks.33 34 The *RapidRecs* executive felt that the study, when considered in context of the full body of evidence, might change practice.35

Our international panel including orthopaedic surgeons, a rheumatologist, physiotherapists, a general practitioner, general internists, epidemiologists, methodologists, and people with lived experience of degenerative knee disease (including those who had undergone and those who had not undergone arthroscopy) met to discuss the evidence. No person had financial conflicts of interest; intellectual and professional conflicts were minimised and managed (see appendix 1 on bmj.com).

The panel followed the *BMJ* Rapid Recommendations procedures for creating a trustworthy recommendation35 36 and used the GRADE approach to critically appraise the evidence and create recommendations (appendix 2).37 The panel considered the balance of benefits, harms, and burdens of the procedure, the quality of evidence for each outcome, typical and expected variations in patient values and preferences, and acceptability. Recommendations can be strong or weak, for or against a course of action.

## The evidence

The panel requested two systematic reviews to inform the recommendation.20 21

The systematic review on the net benefit of knee arthroscopy compared with non-operative care pools data from 13 randomised trials for benefit outcomes (1668 patients) and an additional 12 observational studies for complications (>1.8 million patients).21Figure 2⇓ gives an overview of the patients included, the study funding, and patient involvement in the design of the studies.

![Figure2](https://www.bmj.com/https://www.bmj.com/content/bmj/357/bmj.j1982/F2.medium.gif)

[Figure2](https://www.bmj.com/content/357/bmj.j1982/F2)

**Fig 2** Characteristics of patients and trials included in systematic review of arthroscopic knee surgery

Panel members identified three outcomes—pain, function, and quality of life—as the most important for patients with degenerative knee disease who are considering surgery. Although the included studies reported these patient-important outcomes, it is difficult to know whether changes recorded on an instrument measuring subjective symptoms are important to those with symptoms—for example, a change of three points might have completely different meanings in two different pain scales.

Therefore, a second team performed a linked systematic review addressing what level of individual change on a given scale is important to patients,20 a characteristic called the minimally important difference (MID).22 The study identified a range of credible MIDs for each key outcome; this range of MID estimates informed sensitivity analyses for the review on net benefit, informed discussions on the patient values and preferences, and was key to interpreting the magnitude of effect sizes as well as the strength of the recommendation.20

## Understanding the recommendations

The infographic provides an overview of the benefits and harms of arthroscopy in standard GRADE format. Estimates of baseline risk for effects comes from the control arms of the trials; for complications, comparator risk was assumed to be nil.

The panel is confident that arthroscopic knee surgery does not, on average, result in an improvement in long term pain or function. Most patients will experience an important improvement in pain and function without arthroscopy. However, in <15% of participants, arthroscopic surgery resulted in a small or very small improvement in pain or function at three months after surgery—this benefit was not sustained at one year. In addition to the burden of undergoing knee arthroscopy (see practical issues below), there are rare but important harms, although the precision in these estimates is uncertain (low quality of evidence).

It is unlikely that new information will change interpretation of the key outcomes of pain, knee function, and quality of life (as implied by high to moderate quality of evidence).

The panel is confident that the randomised controlled trials included adequate representation from groups commonly cited to derive benefit from arthroscopic knee surgery for degenerative knee disease—notably those with meniscal tears, no or minimal radiographic evidence of osteoarthritis, and those with sudden but non-traumatic symptom onset. Thus the recommendation applies to all or almost all patients with degenerative knee disease. Further, the evidence applies to patients with any severity of mechanical symptoms, with the only possible exception being those who are objectively unable to fully extend their knee (that is, a true locked knee). We did not consider young patients with sports related injuries or patients with major trauma in any age.

Trials that enrolled a majority of patients without radiographic osteoarthritis showed similar effect sizes to trials enrolling patients with radiographic evidence of osteoarthritis. Most of these trials exclusively included patients with meniscus tears. Meniscus tears are common, usually incidental findings, and unlikely to be the cause of knee pain, aching, or stiffness.1 Mechanical symptoms were also a prominent feature for most trial participants, and many had sudden or subacute onset of symptoms.23 24 25 26 Given that there is evidence of harm and no evidence of important lasting benefit in any subgroup, the panel believes that the burden of proof rests with those who suggest benefit for any other particular subgroup before arthroscopic surgery is routinely performed in any subgroup of patients.

### Practical issues

It takes between two and six weeks to recover from arthroscopy, during which time patients may experience pain, swelling, and limited function.27 28 Most patients cannot bear full weight on the leg (that is, they may need crutches) in the first week after surgery, and driving or physical activity is limited during the recovery period.27Figure 3⇓ outlines the key practical issues for those considering arthroscopic knee surgery versus non-surgical management for degenerative knee disease.

![Figure3](https://www.bmj.com/https://www.bmj.com/content/bmj/357/bmj.j1982/F3.medium.gif)

[Figure3](https://www.bmj.com/content/357/bmj.j1982/F3)

**Fig 3** Practical issues about use of arthroscopic knee surgery versus non-surgical management for degenerative knee disease

Degenerative knee disease is a chronic condition in which symptoms fluctuate. On average, pain tends to improve over time after seeing a physician for pain,21 29 and delaying knee replacement is encouraged when possible.4

### Values and preferences

Our strong recommendation against arthroscopy reflects a low value on a modest probability (<15%) of small or very small improvement in short term pain and function that does not persist to one year, and a higher value on avoiding the burden, postoperative limitations, and rare serious adverse effects associated with knee arthroscopy. The panel, including the patient participants, felt that almost all patients would share these values. The recommendation is not applicable to patients who do not share these values (that is, those who place a high value on a small, uncertain, and transient reduction in pain and function, and a low value on avoiding the burden and postoperative limitation associated with arthroscopy).

### Costs and resources

The panel focused on the patient perspective rather than that of society when formulating the recommendation. However, implementation of this recommendation will almost certainly result in considerable cost savings for health funders. A rigorous economic analysis found that knee arthroscopy for degenerative knee disease is not close to cost effective by traditional standards, even in extreme scenarios that assume a benefit with arthroscopy.30 The panel made a strong recommendation against arthroscopy, which applies to almost all patients with degenerative knee disease, implying that non-use of knee arthroscopy can be used as a performance measure or tied to health funding.31

### Future research

Key research questions to inform decision makers and future guidelines are:

*   Randomised trials—Does arthroscopic knee surgery benefit patients who are objectively unable to fully extend their knee or who have persistent, severe, and frequent mechanical symptoms?

*   Implementation studies—What are the most effective ways to reduce the overuse of arthroscopic surgery for degenerative knee disease?

## Updates to this article

Table 2⇓ shows evidence which has emerged since the publication of this article. As new evidence is published, a group will assess the new evidence and make a judgment on to what extent it is expected to alter the recommendation.

View this table:
[Table 2](https://www.bmj.com/content/357/bmj.j1982/T2)

Table 2 
New evidence which has emerged after initial publication 

#### How patients were involved in the creation of this article:

Three people with lived experience of osteoarthritis, one of whom had arthroscopic knee surgery, were full panel members. These panel members identified important outcomes and led the discussion on values and preferences. Pain was weighed as higher importance for most patients: for example, the patient panel members felt that a possible small benefit to function without a reduction in pain would be unimportant to almost all patients. Those with lived experience identified key practical issues including concerns with cost and accessibility for both arthroscopy and interventions provided by physiotherapists. The members participated in the teleconferences and email discussions and met all authorship criteria.

#### Education into practice

*   •Project: how many arthroscopic procedures are scheduled in your organisation for degenerative knee disease?

*   •Based on the information you have read in this article or in this package of Rapid Recommendation articles, is there anything which you might alter your practice?

*   •To what extent might you use information in this article to alter the conversations you have with patients with degenerative knee disease, or those considering arthroscopic surgery?

## Footnotes

*   This *BMJ Rapid Recommendation* article is one of a series that provides clinicians with trustworthy recommendations for potentially practice changing evidence. *BMJ* Rapid Recommendations represent a collaborative effort between the MAGIC group ([www.magicproject.org](http://www.magicproject.org)) and *The BMJ*. A summary is offered here and the full version including decision aids is on the MAGICapp ([www.magicapp.org](http://www.magicapp.org)), for all devices in multilayered formats. Those reading and using these recommendations should consider individual patient circumstances, and their values and preferences and may want to use consultation decision aids in MAGICapp to facilitate shared decision making with patients. We encourage adaptation and contextualisation of our recommendations to local contexts. Those considering use or adaptation of content may go to MAGICapp to link or extract its content or contact *The BMJ* for permission to reuse content in this article.

*   We thank Alison Hoens for critical review of the recommendation and manuscript. We also thank Tahira Devji for expertly leading the systematic review of minimally important differences.

*   Funding: This guideline was not funded.

*   Competing interests: All authors have completed the *BMJ* Rapid Recommendations interests disclosure form, and a detailed, contextualised description of all disclosures is reported in appendix 1. As with all *BMJ* Rapid Recommendations, the executive team and *The BMJ* judged that no panel member had any financial conflict of interest. Professional and academic interests are minimised as much as possible, while maintaining necessary expertise on the panel to make fully informed decisions.

*   Transparency: R Siemieniuk affirms that the manuscript is an honest, accurate, and transparent account of the recommendation being reported; that no important aspects of the recommendation have been omitted; and that any discrepancies from the recommendation as planned (and, if relevant, registered) have been explained.

This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: [http://creativecommons.org/licenses/by-nc/4.0/](http://creativecommons.org/licenses/by-nc/4.0/).

## References

1.  Englund M, Guermazi A, Gale D, et al. Incidental meniscal findings on knee MRI in middle-aged and elderly persons. N Engl J Med2008;359:1108-15. [doi:10.1056/NEJMoa0800777](http://dx.doi.org/10.1056/NEJMoa0800777) [pmid:18784100](http://www.ncbi.nlm.nih.gov/pubmed/?term=18784100).
    
    

2.  Nguyen US, Zhang Y, Zhu Y, Niu J, Zhang B, Felson DT. Increasing prevalence of knee pain and symptomatic knee osteoarthritis: survey and cohort data. Ann Intern Med2011;155:725-32. [doi:10.7326/0003-4819-155-11-201112060-00004](http://dx.doi.org/10.7326/0003-4819-155-11-201112060-00004) [pmid:22147711](http://www.ncbi.nlm.nih.gov/pubmed/?term=22147711).
    
    

3.  Turkiewicz A, Gerhardsson de Verdier M, Engström G, et al. Prevalence of knee pain and knee OA in southern Sweden and the proportion that seeks medical care. Rheumatology (Oxford)2015;54:827-35. [doi:10.1093/rheumatology/keu409](http://dx.doi.org/10.1093/rheumatology/keu409) [pmid:25313145](http://www.ncbi.nlm.nih.gov/pubmed/?term=25313145).
    
    

4.  McGrory B, Weber K, Lynott JA, et al. American Academy of Orthopaedic Surgeons. The American Academy of Orthopaedic Surgeons evidence-based clinical practice guideline on surgical management of osteoarthritis of the knee. J Bone Joint Surg Am2016;98:688-92. [doi:10.2106/JBJS.15.01311](http://dx.doi.org/10.2106/JBJS.15.01311) [pmid:27098328](http://www.ncbi.nlm.nih.gov/pubmed/?term=27098328).
    
    

5.  Skou ST, Roos EM, Laursen MB, et al. A randomized, controlled trial of total knee replacement. N Engl J Med2015;373:1597-606. [doi:10.1056/NEJMoa1505467](http://dx.doi.org/10.1056/NEJMoa1505467) [pmid:26488691](http://www.ncbi.nlm.nih.gov/pubmed/?term=26488691).
    
    

6.  Jevsevar DS. Treatment of osteoarthritis of the knee: evidence-based guideline, 2nd edition. J Am Acad Orthop Surg2013;21:571-6.[pmid:23996988](http://www.ncbi.nlm.nih.gov/pubmed/?term=23996988).
    
    

7.  National Institute for Health and Clinical Excellence. Arthroscopic knee washout, with or without debridement, for the treatment of osteoarthritis (Interventional procedures guidance IPG230). 2007. [www.nice.org.uk/guidance/ipg230](http://www.nice.org.uk/guidance/ipg230).
    
    

8.  National Institute for Health and Clinical Excellence. Osteoarthritis: care and management (clinical guideline CG177). 2014. [www.nice.org.uk/guidance/cg177](http://www.nice.org.uk/guidance/cg177).
    
    

9.  Beaufils P, Roland B. ESSKA Meniscus Consensus Project. Degenerative meniscus lesions. European Society for Sports Traumatology, Knee Surgery and Arthroscopy, 2016. [http://c.ymcdn.com/sites/www.esska.org/resource/resmgr/Docs/2016-meniscus-consensus-proj.pdf](http://c.ymcdn.com/sites/www.esska.org/resource/resmgr/Docs/2016-meniscus-consensus-proj.pdf).
    
    

10. British Orthopaedic Association, British Association for Surgery of the Knee. BOA/BASK response to media reports regarding knee arthroscopy. 2015. [www.boa.ac.uk/latest-news/boabask-response-to-media-reports-regarding-knee-arthroscopy/](http://www.boa.ac.uk/latest-news/boabask-response-to-media-reports-regarding-knee-arthroscopy/).
    
    

11. Australian Knee Society on Arthroscopic Surgery of the Knee. Position statement from the Australian Knee Society on Arthroscopic Surgery of the Knee, including reference to the presence of osteoarthritis or degenerative joint disease. 2016. [www.kneesociety.org.au/resources/aks-arthroscopy-position-statement.pdf](http://www.kneesociety.org.au/resources/aks-arthroscopy-position-statement.pdf).
    
    

12. Zhang W, Moskowitz RW, Nuki G, et al. OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines. Osteoarthritis Cartilage2008;16:137-62. [doi:10.1016/j.joca.2007.12.013](http://dx.doi.org/10.1016/j.joca.2007.12.013) [pmid:18279766](http://www.ncbi.nlm.nih.gov/pubmed/?term=18279766).
    
    

13. Zhang W, Nuki G, Moskowitz RW, et al. OARSI recommendations for the management of hip and knee osteoarthritis: part III: Changes in evidence following systematic cumulative update of research published through January 2009. Osteoarthritis Cartilage2010;18:476-99. [doi:10.1016/j.joca.2010.01.013](http://dx.doi.org/10.1016/j.joca.2010.01.013) [pmid:20170770](http://www.ncbi.nlm.nih.gov/pubmed/?term=20170770).
    
    

14. Cullen KA, Hall MJ, Golosinskiy A. Ambulatory surgery in the United States, 2006. Natl Health Stat Report2009;(11):1-25.[pmid:19294964](http://www.ncbi.nlm.nih.gov/pubmed/?term=19294964).
    
    

15. Adelani MA, Harris AH, Bowe TR, Giori NJ. Arthroscopy for knee osteoarthritis has not decreased after a clinical trial. Clin Orthop Relat Res2016;474:489-94. [doi:10.1007/s11999-015-4514-4](http://dx.doi.org/10.1007/s11999-015-4514-4) [pmid:26290345](http://www.ncbi.nlm.nih.gov/pubmed/?term=26290345).
    
    

16. Bohensky MA, Sundararajan V, Andrianopoulos N, et al. Trends in elective knee arthroscopies in a population-based cohort, 2000-2009. Med J Aust2012;197:399-403. [doi:10.5694/mja11.11645](http://dx.doi.org/10.5694/mja11.11645) [pmid:23025737](http://www.ncbi.nlm.nih.gov/pubmed/?term=23025737).
    
    

17. Hamilton DF, Howie CR. Knee arthroscopy: influence of systems for delivering healthcare on procedure rates. BMJ2015;351:h4720. [doi:10.1136/bmj.h4720](http://dx.doi.org/10.1136/bmj.h4720) [pmid:26405226](http://www.ncbi.nlm.nih.gov/pubmed/?term=26405226).
    
    

18. Thorlund JB, Hare KB, Lohmander LS. Large increase in arthroscopic meniscus surgery in the middle-aged and older population in Denmark from 2000 to 2011. Acta Orthop2014;85:287-92. [doi:10.3109/17453674.2014.919558](http://dx.doi.org/10.3109/17453674.2014.919558) [pmid:24800623](http://www.ncbi.nlm.nih.gov/pubmed/?term=24800623).
    
    

19. Järvinen TL, Guyatt GH. Arthroscopic surgery for knee pain. BMJ2016;354:i3934. [doi:10.1136/bmj.i3934](http://dx.doi.org/10.1136/bmj.i3934) [pmid:27439983](http://www.ncbi.nlm.nih.gov/pubmed/?term=27439983).
    
    

20. Devji T, Guyatt GH, Lytvyn L, et al. Application of minimal important differences in degenerative knee disease outcomes: a systematic review and case study to inform BMJ Rapid Recommendations. BMJ Open2017;7:e015587. [doi:10.1136/bmjopen-2016-015587](http://dx.doi.org/10.1136/bmjopen-2016-015587).
    
    

21. Brignardello-Peterson R, Guyatt GH, Schandelmaier S, et al. Knee arthroscopy versus conservative management in patients with degenerative knee disease: a systematic review. BMJ Open2017;7:e016114. [doi:10.1136/bmjopen-2017-016114](http://dx.doi.org/10.1136/bmjopen-2017-016114).
    
    

22. Guyatt GH, Juniper EF, Walter SD, Griffith LE, Goldstein RS. Interpreting treatment effects in randomised trials. BMJ1998;316:690-3. [doi:10.1136/bmj.316.7132.690](http://dx.doi.org/10.1136/bmj.316.7132.690) [pmid:9522799](http://www.ncbi.nlm.nih.gov/pubmed/?term=9522799).
    
    

23. Gauffin H, Tagesson S, Meunier A, Magnusson H, Kvist J. Knee arthroscopic surgery is beneficial to middle-aged patients with meniscal symptoms: a prospective, randomised, single-blinded study. Osteoarthritis Cartilage2014;22:1808-16. [doi:10.1016/j.joca.2014.07.017](http://dx.doi.org/10.1016/j.joca.2014.07.017) [pmid:25086401](http://www.ncbi.nlm.nih.gov/pubmed/?term=25086401).
    
    

24. Kirkley A, Birmingham TB, Litchfield RB, et al. A randomized trial of arthroscopic surgery for osteoarthritis of the knee. N Engl J Med2008;359:1097-107. [doi:10.1056/NEJMoa0708333](http://dx.doi.org/10.1056/NEJMoa0708333) [pmid:18784099](http://www.ncbi.nlm.nih.gov/pubmed/?term=18784099).
    
    

25. Sihvonen R, Englund M, Turkiewicz A, Järvinen TL. Finnish Degenerative Meniscal Lesion Study Group. Mechanical symptoms and arthroscopic partial meniscectomy in patients with degenerative meniscus tear: a secondary analysis of a randomized trial. Ann Intern Med2016;164:449-55. [doi:10.7326/M15-0899](http://dx.doi.org/10.7326/M15-0899) [pmid:26856620](http://www.ncbi.nlm.nih.gov/pubmed/?term=26856620).
    
    

26. Sihvonen R, Paavola M, Malmivaara A, et al. Finnish Degenerative Meniscal Lesion Study (FIDELITY) Group. Arthroscopic partial meniscectomy versus sham surgery for a degenerative meniscal tear. N Engl J Med2013;369:2515-24. [doi:10.1056/NEJMoa1305189](http://dx.doi.org/10.1056/NEJMoa1305189) [pmid:24369076](http://www.ncbi.nlm.nih.gov/pubmed/?term=24369076).
    
    

27. Lubowitz JH, Ayala M, Appleby D. Return to activity after knee arthroscopy. Arthroscopy2008;24:58-61.e4. [doi:10.1016/j.arthro.2007.07.026](http://dx.doi.org/10.1016/j.arthro.2007.07.026) [pmid:18182203](http://www.ncbi.nlm.nih.gov/pubmed/?term=18182203).
    
    

28. Pihl K, Roos EM, Nissen N, JøRgensen U, Schjerning J, Thorlund JB. Over-optimistic patient expectations of recovery and leisure activities after arthroscopic meniscus surgery. Acta Orthop2016;87:615-21. [doi:10.1080/17453674.2016.1228411](http://dx.doi.org/10.1080/17453674.2016.1228411) [pmid:27622598](http://www.ncbi.nlm.nih.gov/pubmed/?term=27622598).
    
    

29. de Rooij M, van der Leeden M, Heymans MW, et al. Prognosis of pain and physical functioning in patients with knee osteoarthritis: a systematic review and meta-analysis. Arthritis Care Res (Hoboken)2016;68:481-92. [doi:10.1002/acr.22693](http://dx.doi.org/10.1002/acr.22693) [pmid:26316234](http://www.ncbi.nlm.nih.gov/pubmed/?term=26316234).
    
    

30. Marsh JD, Birmingham TB, Giffin JR, et al. Cost-effectiveness analysis of arthroscopic surgery compared with non-operative management for osteoarthritis of the knee. BMJ Open2016;6:e009949. [doi:10.1136/bmjopen-2015-009949](http://dx.doi.org/10.1136/bmjopen-2015-009949) [pmid:26758265](http://www.ncbi.nlm.nih.gov/pubmed/?term=26758265).
    
    

31. Andrews JC, Schünemann HJ, Oxman AD, et al. GRADE guidelines: 15. Going from evidence to recommendation-determinants of a recommendation’s direction and strength. J Clin Epidemiol2013;66:726-35. [doi:10.1016/j.jclinepi.2013.02.003](http://dx.doi.org/10.1016/j.jclinepi.2013.02.003) [pmid:23570745](http://www.ncbi.nlm.nih.gov/pubmed/?term=23570745).
    
    

32. Kise NJ, Risberg MA, Stensrud S, Ranstam J, Engebretsen L, Roos EM. Exercise therapy versus arthroscopic partial meniscectomy for degenerative meniscal tear in middle aged patients: randomised controlled trial with two year follow-up. BMJ2016;354:i3740. [doi:10.1136/bmj.i3740](http://dx.doi.org/10.1136/bmj.i3740) [pmid:27440192](http://www.ncbi.nlm.nih.gov/pubmed/?term=27440192).
    
    

33. Khan M, Evaniew N, Bedi A, Ayeni OR, Bhandari M. Arthroscopic surgery for degenerative tears of the meniscus: a systematic review and meta-analysis. CMAJ2014;186:1057-64. [doi:10.1503/cmaj.140433](http://dx.doi.org/10.1503/cmaj.140433) [pmid:25157057](http://www.ncbi.nlm.nih.gov/pubmed/?term=25157057).
    
    

34. Thorlund JB, Juhl CB, Roos EM, Lohmander LS. Arthroscopic surgery for degenerative knee: systematic review and meta-analysis of benefits and harms. BMJ2015;350:h2747. [doi:10.1136/bmj.h2747](http://dx.doi.org/10.1136/bmj.h2747) [pmid:26080045](http://www.ncbi.nlm.nih.gov/pubmed/?term=26080045).
    
    

35. Siemieniuk RA, Agoritsas T, Macdonald H, Guyatt GH, Brandt L, Vandvik PO. Introduction to BMJ Rapid Recommendations. BMJ2016;354:i5191. [doi:10.1136/bmj.i5191](http://dx.doi.org/10.1136/bmj.i5191) [pmid:27680768](http://www.ncbi.nlm.nih.gov/pubmed/?term=27680768).
    
    

36. Vandvik PO, Otto CM, Siemieniuk RA, et al. Transcatheter or surgical aortic valve replacement for patients with severe, symptomatic, aortic stenosis at low to intermediate surgical risk: a clinical practice guideline. BMJ2016;354:i5085. [doi:10.1136/bmj.i5085](http://dx.doi.org/10.1136/bmj.i5085) [pmid:27680583](http://www.ncbi.nlm.nih.gov/pubmed/?term=27680583).
    
    

37. Guyatt GH, Oxman AD, Vist GE, et al. GRADE Working Group. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ2008;336:924-6. [doi:10.1136/bmj.39489.470347.AD](http://dx.doi.org/10.1136/bmj.39489.470347.AD) [pmid:18436948](http://www.ncbi.nlm.nih.gov/pubmed/?term=18436948).